01/03/2025
1:22 PM | Gottfurcht Grant (Reporting)
Sonoma Pharmaceuticals (Subject)
| Form 144/A | |
01/03/2025
1:27 PM | Gottfurcht Grant (Reporting)
Sonoma Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
1:15 PM | Gottfurcht Grant (Reporting)
Sonoma Pharmaceuticals (Subject)
| Form 144/A | |
01/02/2025
2:39 PM | Gottfurcht Grant (Reporting)
Sonoma Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
10:13 AM | Gottfurcht Grant (Reporting)
Sonoma Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
2:40 PM | Gottfurcht Grant (Reporting)
Sonoma Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
4:01 PM | Sonoma Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/21/2024
3:01 PM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
7:36 AM | Sonoma Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/22/2024
7:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
5:00 AM | Sonoma Pharmaceuticals (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for SNOA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
09/20/2024
5:02 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
5:03 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
7:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:49 PM | Sonoma Pharmaceuticals (Filer)
| Form DEFA14A | |
08/14/2024
7:53 PM | Sonoma Pharmaceuticals (Filer)
| Form DEFA14A | |
07/24/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form DEFA14A | |
07/01/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form DEF 14A | |
06/27/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 424B5 | |
06/27/2024
6:31 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:56 PM | Sonoma Pharmaceuticals (Filer)
| Form PRE 14A | |
06/21/2024
4:05 PM | Dal Poggetto John (Reporting)
Sonoma Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:05 PM | DVONCH JEROME J (Reporting)
Sonoma Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:05 PM | Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:06 PM | Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:30 PM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
